sanguinarine has been researched along with biguanides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciancio, SG | 1 |
| Bettis, S; Boxer, MB; Chiang, CY; Curtis, M; Ferrer, M; Jadhav, A; Kenny, HA; Lal-Nag, M; Lengyel, E; Li, Z; Mitra, AK; Schryver, EM; Shen, M; White, EA; Zhang, Y | 1 |
2 other study(ies) available for sanguinarine and biguanides
| Article | Year |
|---|---|
Drugs in dentistry. Agents for plaque control.
Topics: Alkaloids; Anti-Infective Agents; Benzophenanthridines; Biguanides; Dental Plaque; Humans; Isoquinolines; Oils, Volatile; Quaternary Ammonium Compounds; Tin Fluorides | 1986 |
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Biguanides; Cantharidin; Cell Adhesion; Cell Movement; Cell Proliferation; Coculture Techniques; Epithelial Cells; Escin; Extracellular Matrix; Female; Fibroblasts; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Nude; Ovarian Neoplasms; Primary Cell Culture; Prochlorperazine; Tomatine; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |